Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 167 member B (**FAM167B**) is a gene encoding a protein (sometimes called *DIORA-2*) that is highly intrinsically disordered, meaning it lacks a defined tertiary structure[1][2][5]. This protein is evolutionarily conserved and shares its family with FAM167A, but does not have homologs outside FAM167A/FAM167B and is not related to any well-characterized protein domain or motif[2]. FAM167B is 163 amino acids long, with a predicted molecular weight of approximately 18.4 kDa[2][5]. Its expression and subcellular localization are not well defined, and its biological function remains largely unknown. FAM167B is not currently recognized as a therapeutic target, biomarker, or disease gene, although its related protein FAM167A has been studied for associations with autoimmune disease risk. The gene is annotated under several previous names, most notably **C1orf90**, and "Disordered autoimmunity 2" refers to its structural property. Research on FAM167B is ongoing, with large gaps in knowledge about its cellular roles and disease relevance[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 167 member B (FAM167B).